Advit Jewels IPO: Should You Subscribe for 46% Listing Gains?

prosumit999@gmail.com

0 Comments

The Advit Jewels IPO GMP stands at ₹64 per share on June 22, 2026, representing a 46.38% premium over the upper price band of ₹138. The grey market premium touched ₹91 on June 15 before easing to its current level. The revenue and profit trajectory is precisely what the market rewards ahead of a subscription opening: revenue from operations rose 79.9% to ₹124.94 crore in FY25, and profit after tax rose 72.5% to ₹25.37 crore. Three brokerages have recommended subscribing.

The detail that separates this IPO from the bullish consensus around it is the working capital structure. The company is growing its profits while running negative operating cash flows, building inventory, and carrying debt it plans to repay from the IPO proceeds.

The listing pop that the GMP is signalling has a reasonable probability of materialising. The post-listing story has a question attached to it that no brokerage note has yet answered directly.

Key Takeaways ON Advit Jewels IPO GMP

• Advit Jewels IPO GMP is ₹64 on June 22, a 46.38% premium over the ₹138 upper price band, but down from a peak of ₹91 on June 15.
• The ₹165.16 crore IPO is entirely a fresh issue of 1.20 crore shares with no OFS component, meaning all proceeds go to the company.
• Revenue rose 79.9% to ₹124.94 crore and PAT rose 72.5% to ₹25.37 crore in FY25, with nine-month FY26 PAT already at ₹25.44 crore.
• SMIFS, Marwadi Financial Services, and SBI Securities have assigned Subscribe ratings; SMIFS values the company at 17x FY25 earnings.
• The IPO opens June 23, closes June 25, with allotment on June 29 and listing on NSE and BSE on July 1.

Advit Jewels IPO: The Full Data Table

The Five Growth Catalysts Driving the Bull Case

The GMP is not speculative noise. It is anchored to specific growth drivers that brokerages have identified and that the financials partially validate. Here are the five catalysts underpinning the Subscribe ratings.

1. Revenue and PAT Momentum with Nine-Month Visibility

Revenue grew at a compound annual growth rate of 63.7% between FY23 and FY25. PAT grew at 56.2% over the same period. The nine-month PAT for FY26 already stands at ₹25.44 crore, exceeding the full-year FY25 figure of ₹25.37 crore. This means the company entered the IPO window with demonstrable earnings momentum rather than a single good year. The revenue jump from ₹69.44 crore to ₹124.94 crore in one year is the kind of inflection point that institutional investors treat as an entry signal.

2. Asset-Light Retail Expansion into Tier-I and Tier-II Cities

The company operates primarily through a B2B model, selling to dealers, retailers, and jewellery showrooms. The post-IPO strategy includes a franchise-led retail rollout across Tier-I and Tier-II cities, anchored by a 27,790 square foot flagship showroom in Jaipur. The franchise model is asset-light. The capital expenditure is borne by franchisees. The company supplies product and brand. If executed, this shifts the revenue mix toward higher-margin B2C sales without the balance sheet strain of company-owned retail.

3. A Brand That Predates the Company

The Rambhajo brand has roots tracing to 1921, nearly a century before the company was incorporated in 2019. This is unusual for a seven-year-old corporate entity. The brand has dressed Shraddha Kapoor, Deepika Padukone, Kangana Ranaut, Madhuri Dixit, and other public figures. In the jewellery business, trust is purchased over decades or borrowed from heritage. Advit Jewels has the latter, and it is deploying it through a modern corporate structure that did not exist five years ago.

4. A 100% Fresh Issue with Promoters Retaining Full Stake

No promoter shares are being sold. No venture capital or private equity shares are being offloaded. The entire ₹165.16 crore is new equity entering the company. This structure aligns promoter interests with public shareholders from day one. It also means the book value per share will rise post-IPO because the fresh capital is additive, not replacing exiting shareholders.

5. A P/E Multiple That Sits in a Peer-Validated Range

At the upper price band, the company trades at 24.9x FY25 earnings and 18.6x annualised FY26 earnings. The peer set is instructive not because it provides a target multiple but because it shows the range of outcomes the market assigns to jewellery companies. RBZ Jewellers at 10x is a value trade. Bluestone at 542x is a growth speculation. Advit at 17-25x sits in the reasonable-growth band. SMIFS explicitly cited the 17x multiple as attractive relative to growth potential.

The Five Risk Factors the GMP Is Not Discounting

The bull case has been well documented by brokerages and competitor articles. The risk case has been mentioned but never fully developed. These are the five numbers that will determine whether the post-listing returns match the listing pop.

1. Negative Operating Cash Flow Despite Positive PAT

This is the gap at the centre of the IPO. The company reported PAT of ₹25.37 crore in FY25. Its operating cash flow was negative. The mechanism is not mysterious. A jewellery manufacturer must purchase gold, manufacture inventory, and sell it before cash returns. When revenue grows at 79.9%, the cash going into inventory grows faster than the cash coming back from sales. This is normal in a growth phase. It is also the reason the company is raising capital for working capital. The risk is not the negative cash flow itself. It is the assumption that the cash flow will turn positive once growth stabilises. That has not been demonstrated yet.

2. Inventory Buildup Outpacing Revenue Growth

The company’s total assets as of December 2025 were ₹164 crore. A significant portion of that is inventory. For a jewellery company, inventory is both the revenue engine and the single largest balance sheet risk. Gold price fluctuations can erode inventory value. Fashion cycles can render designs unsellable. Kundan and Polki jewellery is high-value and low-velocity. Pieces can sit in inventory for extended periods. The company has not disclosed the inventory turnover ratio in the public domain, and that specific number is what a long-term investor needs to track from the first quarterly filing after listing.

3. Debt That the IPO Repays but Does Not Eliminate the Need For

The IPO proceeds include an allocation for debt repayment. The company has been borrowing to fund its working capital cycle. The fresh equity will reduce the debt on the balance sheet. It will not change the fact that the business model requires continuous working capital financing. If inventory continues to grow, the company will either need to raise debt again or generate enough operating cash flow to self-fund. The first option returns the company to a leveraged position. The second option requires a cash flow turnaround that has not yet occurred.

4. Gold Price and Seasonal Demand Dependency

The company buys gold at market prices and sells finished jewellery. Gold price volatility affects both the cost of raw material and the affordability for end consumers. The jewellery business is also disproportionately dependent on the festive and wedding season. A weak Diwali or a subdued wedding season can leave the company holding inventory it cannot move. This is not a risk specific to Advit Jewels. It is a sector-wide risk that every jewellery company carries. The difference is that a company growing at 79.9% has more inventory at risk at any given moment than a company growing at 10%.

5. Supplier and Customer Concentration in a B2B-Dominant Model

The company operates primarily through B2B channels. A limited number of dealers, retailers, and jewellery showrooms account for a significant share of revenue. The red herring prospectus contains the specific concentration figures. Any customer representing more than 20-30% of revenue is a risk factor. The loss of one large dealer relationship can alter the revenue trajectory materially. On the supplier side, the gold and diamond supply chain in Jaipur is concentrated. A disruption in raw material availability or a sharp change in supplier credit terms can compress margins.

The Split Decision: Listing Gains Versus Long-Term Holding

The Advit Jewels IPO is a cleaner proposition for listing-day applicants than it is for long-term investors. The 46% GMP provides a buffer. Even if the premium compresses further between June 22 and July 1, a double-digit listing gain is probable unless broader market sentiment deteriorates sharply. The minimum investment of ₹13,800 is accessible, and the lot size of 100 shares is retail-friendly. The anchor investor response on June 22 will provide an additional data point. Strong institutional demand at the upper price band would validate the GMP signal.

For long-term investors, the equation is different. The company is well-managed, growing fast, and operating in a niche, Kundan-Polki handcrafted jewellery, where it has genuine brand equity. The expansion into B2C retail, the franchise rollout, and the flagship showroom are real catalysts. The valuations at 17-25x earnings are defensible given the growth rate.

The risk is that the company’s financial structure has not yet demonstrated it can convert profit growth into cash flow. The IPO proceeds will strengthen the balance sheet temporarily. The test is whether the company can generate positive operating cash flow from the expanded inventory base that the IPO is funding. The first two quarterly filings after listing will answer that question. Until then, the investment case for a long-term hold is a bet on execution that the numbers have not yet confirmed.

The most widespread misconception in the public conversation is that a 46% GMP means the IPO is low-risk. It means the opposite. A high GMP attracts leveraged NII applications and flipper capital that exits on listing day. The stock will discover its true price only after that money has left.

The investors who buy on listing day will be buying a company with strong revenue growth, rising inventory, negative cash flow, and a management team that has not yet operated as a public company. That is not a negative description. It is an accurate description. The decision to be one of those investors should be made with those facts, not just with the GMP.

The aspect of this IPO that is most overlooked is the simplest. A ₹165 crore fresh issue that strengthens a ₹632 crore market cap company by roughly 26% is a meaningful recapitalisation. It changes the balance sheet. It does not change the business model. The business model will be tested in the quarters after July 1. The GMP is pricing in the balance sheet change. It is not pricing in the business model test because that test has not started yet.

✈

Written by

prosumit999@gmail.com